Literature DB >> 26849918

Emerging landscape of cell penetrating peptide in reprogramming and gene editing.

Huiting Liu1, Fanhui Zeng2, Ming Zhang3, Fajun Huang4, Jiajun Wang5, Jingjing Guo6, Changbai Liu7, Hu Wang8.   

Abstract

The plasma membrane remains a major barrier for intracellular drug delivery, to overcome this issue, a variety of approaches have been developed and used to deliver therapeutic cargos. Among these approaches, cell penetrating peptide (CPP) is promising and affords widely used vector for efficient intracellular delivery of cargos. Moreover, the latter findings including iPS reprogramming and direct transdifferentiation as well as gene editing have gradually become hot research topic; because their application in tissue engineering and disease modeling have great potential to advance innovation in precision medicine. Since the beginning, research on these approaches is mainly based on virus transduction system, while, under the consideration for obviating the risk of mutagenic insertion and enables more accurate controlling, CPP-based efficient virus-free delivery strategy has been used recently. In this review, we summarize the existing CPP-based delivery system, emerging landscape of CPP application in stem cell manipulation and reprogramming, along with CPP contributions to gene editing techniques.
Copyright © 2016 Elsevier B.V. All rights reserved.

Keywords:  Cell penetrating peptide; Gene editing; Reprogramming; Stem cells

Mesh:

Substances:

Year:  2016        PMID: 26849918     DOI: 10.1016/j.jconrel.2016.02.002

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  10 in total

1.  Modification of Human Umbilical Cord Blood Stem Cells Using Polyethylenimine Combined with Modified TAT Peptide to Enhance BMP-2 Production.

Authors:  Yufu Wang; Changcheng You; Rongzhi Wei; Jianing Zu; Chengchao Song; Jing Li; Jinglong Yan
Journal:  Biomed Res Int       Date:  2017-08-17       Impact factor: 3.411

2.  TRAIL mutant membrane penetrating peptide alike-MuR6-TR enhances the antitumor effects of TRAIL in pancreatic carcinoma both in vitro and in vivo.

Authors:  Lei Sun; Chen Chen; Aijing Zhu; Ying Huang; Hong Zhu; Cheng Yi
Journal:  Int J Mol Med       Date:  2017-04-26       Impact factor: 4.101

3.  Efficient therapeutic delivery by a novel cell-permeant peptide derived from KDM4A protein for antitumor and antifibrosis.

Authors:  Hu Wang; Jie-Lan Ma; Ying-Gui Yang; Yang Song; Jiao Wu; Yan-Yan Qin; Xue-Li Zhao; Jun Wang; Li-Li Zou; Jiang-Feng Wu; Jun-Ming Li; Chang-Bai Liu
Journal:  Oncotarget       Date:  2016-08-02

Review 4.  Recent Development of Nuclear Molecular Imaging in Thyroid Cancer.

Authors:  Huiting Liu; Xiaoqin Wang; Ran Yang; Wenbing Zeng; Dong Peng; Jason Li; Hu Wang
Journal:  Biomed Res Int       Date:  2018-05-21       Impact factor: 3.411

5.  Intracellular Delivery of DNA and Protein by a Novel Cell-Permeable Peptide Derived from DOT1L.

Authors:  Jingping Geng; Xiangli Guo; Lidan Wang; Richard Q Nguyen; Fengqin Wang; Changbai Liu; Hu Wang
Journal:  Biomolecules       Date:  2020-02-02

Review 6.  The Role of Cell Division Autoantigen 1 (CDA1) in Renal Fibrosis of Diabetic Nephropathy.

Authors:  LinLin Chen; Jiao Wu; Bin Hu; Changbai Liu; Hu Wang
Journal:  Biomed Res Int       Date:  2021-04-28       Impact factor: 3.411

7.  Improved transfer efficiency of supercharged 36 + GFP protein mediate nucleic acid delivery.

Authors:  Lidan Wang; Jingping Geng; Linlin Chen; Xiangli Guo; Tao Wang; Yanfen Fang; Bonn Belingon; Jiao Wu; Manman Li; Ying Zhan; Wendou Shang; Yingying Wan; Xuemei Feng; Xianghui Li; Hu Wang
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.419

8.  In silico identification and experimental validation of cellular uptake and intracellular labeling by a new cell penetrating peptide derived from CDN1.

Authors:  Xiangli Guo; Linlin Chen; Lidan Wang; Jingping Geng; Tao Wang; Jixiong Hu; Jason Li; Changbai Liu; Hu Wang
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

9.  Hyperosmotic treatment synergistically boost efficiency of cell-permeable peptides.

Authors:  Hu Wang; Ming Zhang; Fanhui Zeng; Changbai Liu
Journal:  Oncotarget       Date:  2016-11-15

10.  In silico identification and experimental validation of cellular uptake by a new cell penetrating peptide P1 derived from MARCKS.

Authors:  Linlin Chen; Xiangli Guo; Lidan Wang; Jingping Geng; Jiao Wu; Bin Hu; Tao Wang; Jason Li; Changbai Liu; Hu Wang
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.